NMPA grants BTD to Innovent’s olverembatinib to treat SDH-deficient GIST

Olverembatinib is intended for the treatment of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumour. Credit: Olga Guryanova on Unsplash.